𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mortality and cancer incidence in patients with Parkinson's disease

✍ Scribed by Yuko Minami; Reiko Yamamoto; Mitsuaki Nishikouri; Akira Fukao; Shigeru Hisamichi


Book ID
106096162
Publisher
Springer
Year
2000
Tongue
English
Weight
116 KB
Volume
247
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Mortality of patients with parkinson's d
✍ R. J. Marttila; U. K. Rinne; T. Siirtola; V. Sonninen πŸ“‚ Article πŸ“… 1977 πŸ› Springer 🌐 English βš– 372 KB

The effect of levodopa on the mortality of patients with Parkinson's disease was investigated in 349 patients treated with levodopa or levodopa combined with decarboxylase inhibitor during 1969-1975 inclusive. During the study period, 61 patients died. The expected mortality was 32.99 resulting in a

Selegiline and mortality in Parkinson's
✍ Dr. C. W. Olanow; S. Fahn; J. W. Langston; J. Godbold πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 489 KB πŸ‘ 2 views

## Do Other Studies Show Increased Mortality Due to Selegiline? Other than the UK study, no clinical trial to date has shown an increase in mortality in association with the use of selegiline. In the Sindepar study, a cohort of I01 untreated P D patients participated in a 14-month prospective, ran

Mortality in Parkinson's disease
✍ Kurt A. Jellinger πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 47 KB
Long-term efficacy and mortality in Park
✍ Mathias Toft; BΓ₯rd Lilleeng; Jon Ramm-Pettersen; Inger Marie Skogseid; Vidar Gun πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 678 KB

## Background: The objective of this study was to examine the clinical outcome and mortality of long-term deep brain stimulation of the subthalamic nucleus in advanced parkinson's disease. ## Methods: We included all 144 patients (mean age, 60.3 years; mean disease duration, 11.0 years) treated i